Examining the origin of posttransplant lymphoproliferative disorder in a patient after a second allogeneic hematopoeitic stem cell transplantation for relapsed BCR-ABL positive acute lymphoblastic leukemia

Journal of Pediatric Hematology/Oncology

Volumn 33, Issue 1, 2011, Pages 50-54

  Ruf, Stephanie ^a   Moser, Olga ^a   Wömann, Wilhelm ^a   Kreyenberg, Hermann ^b   Wagner, Hans Joachim ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Epstein Barr virus; hematopoietic stem cell; posttransplant lymphoproliferative disorder

Indexed keywords

BCR ABL PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; B LYMPHOCYTE; CANCER RELAPSE; CASE REPORT; CHIMERA; EPSTEIN BARR VIRUS; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPHOPROLIFERATIVE DISEASE; MALE; PRIORITY JOURNAL; RETRANSPLANTATION; SHORT TANDEM REPEAT; T LYMPHOCYTE;

ADOLESCENT; B-LYMPHOCYTES; EPSTEIN-BARR VIRUS INFECTIONS; FUSION PROTEINS, BCR-ABL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOPROLIFERATIVE DISORDERS; MALE; POSTOPERATIVE COMPLICATIONS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECURRENCE; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 78650794389     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181ed336f     Document Type: Article

References (13)

1. Gottschalk S, Rooney CM, Heslop HE. Post-transplant lymphoproliferative disorders. Annu Rev Med. 2005;56:29-44.
2. Timms JM, Bell A, Flavell JR, et al. Targets of Epstein-Barr virus (EBS)-positive post-transplant lymphoproliferative disease: Similarities to EBV-positive Hodgkin's lymphoma. Lancet. 2003;361:217-223.
3. Shapiro RS, McClain K, Frizzera G, et al. Epstein-Barr virus associated B cell lymphoproliferation disorders following bone marrow transplantation. Blood. 1988;71:1234-1243.
4. Kreyenberg H, Hoelle W, Moehrle S, et al. Quantitative analysis of chimersim after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: The Tuebingen experience. Leukemia. 2003;17:237-240.
5. Kasow AK, Leung W, Horwitz EM, et al. EBV lymphoproliferative disease of host origin after haploidentical stem cell transplantation. Pediatr Blood Cancer. 2007;49:869-872.
6. Wy A, Lie AK, Lee CK, et al. Late onset post-transplantation lymphoproliferative disease of recipient origin following cytogenetic relapse and occult autologous haematopoietic regeneration after allogeneic bone marrow transplantation for acute myeloid leukaemia. Bone Marrow Transplant. 2001; 28:417-419.
7. Gong JZ, Bayerl MG, Sandhaus LM, et al. Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children. Am J Surg Pathol. 2006;30: 328-336.
8. Synder MJ, Stenzel TT, Buckley PJ, et al. Posttransplant lymphoproliferative disorder following nonmyeloablative allogeneic stem cell transplantation. Am J Surg Pathol. 2004; 28:794-800.
9. Reddiconto G, Chiusolo P, Fiorini A, et al. Assessment of cellular origin and EBV status in a PTLD after double cord blood transplantation. Leukemia. 2007;21:2552-2554.
10. Styczynski J, Einsele H, de la Camara R, et al. New Guiedelines for the Management of Bacterial, Fungal and Viral Infections (ECIL2). Recommendations for EBV management [ELN, European LeukemiaNet]. Available at: Http//www.leukemia-net.org/content/home/search-eng.html?searchform= 0&raw=ecil2. (Accessed February 8, 2010).
11. Styczynski J, Einsele H, Ljungman P. Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: A comprehensive review of reported cases. Transpl Infect Dis. 2009;11: 383-392.
12. Nishida A, Yamamoto H, Ohta Y, et al. T-cell post-transplant lymphoproliferative disorder in a patient with chronic idiopathic myelofibrosis following allogeneic PBSC transplantation. Bone Marrow Transplant. 2010;45:1372-1374.
13. Awaya N, Adachi A, Mori T, et al. Fulminant Epstein-Barr virus (EBV)-associated T-cell lymphoproliferative disorder with hemophagocytosis follwing autologous peripheral blood stem cell transplantation for relapsed angioimmunoblastic T-cell lymphoma. Leuk Res. 2006;30:1059-1062.